Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9934454rdf:typepubmed:Citationlld:pubmed
pubmed-article:9934454lifeskim:mentionsumls-concept:C0019588lld:lifeskim
pubmed-article:9934454lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9934454lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:9934454lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:9934454lifeskim:mentionsumls-concept:C0032172lld:lifeskim
pubmed-article:9934454lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:9934454lifeskim:mentionsumls-concept:C1554184lld:lifeskim
pubmed-article:9934454lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:9934454pubmed:issue24lld:pubmed
pubmed-article:9934454pubmed:dateCreated1999-4-5lld:pubmed
pubmed-article:9934454pubmed:abstractTextA series of N-acyl-4-(5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin- 11-ylidene)piperazines is described that are dual antagonists of PAF and histamine. The structural requirements for activity in this series parallel those of their previously reported piperidinylidene counterparts. Whereas their global minimum energy conformations are different for both series of compounds, computer assisted molecular modeling suggests that a common bioactive conformation is possible.lld:pubmed
pubmed-article:9934454pubmed:languageenglld:pubmed
pubmed-article:9934454pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9934454pubmed:citationSubsetIMlld:pubmed
pubmed-article:9934454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9934454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9934454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9934454pubmed:statusMEDLINElld:pubmed
pubmed-article:9934454pubmed:monthDeclld:pubmed
pubmed-article:9934454pubmed:issn0960-894Xlld:pubmed
pubmed-article:9934454pubmed:authorpubmed-author:BillahM MMMlld:pubmed
pubmed-article:9934454pubmed:authorpubmed-author:KaminskiJ JJJlld:pubmed
pubmed-article:9934454pubmed:authorpubmed-author:GreenM JMJlld:pubmed
pubmed-article:9934454pubmed:authorpubmed-author:GangulyA KAKlld:pubmed
pubmed-article:9934454pubmed:authorpubmed-author:WongJ KJKlld:pubmed
pubmed-article:9934454pubmed:authorpubmed-author:WestR EREJrlld:pubmed
pubmed-article:9934454pubmed:authorpubmed-author:AnthesJ CJClld:pubmed
pubmed-article:9934454pubmed:authorpubmed-author:ColizzoFFlld:pubmed
pubmed-article:9934454pubmed:authorpubmed-author:PiwinskiJ JJJlld:pubmed
pubmed-article:9934454pubmed:authorpubmed-author:AlbaneseM MMMlld:pubmed
pubmed-article:9934454pubmed:issnTypePrintlld:pubmed
pubmed-article:9934454pubmed:day15lld:pubmed
pubmed-article:9934454pubmed:volume8lld:pubmed
pubmed-article:9934454pubmed:ownerNLMlld:pubmed
pubmed-article:9934454pubmed:authorsCompleteYlld:pubmed
pubmed-article:9934454pubmed:pagination3469-74lld:pubmed
pubmed-article:9934454pubmed:dateRevised2001-3-23lld:pubmed
pubmed-article:9934454pubmed:meshHeadingpubmed-meshheading:9934454-...lld:pubmed
pubmed-article:9934454pubmed:meshHeadingpubmed-meshheading:9934454-...lld:pubmed
pubmed-article:9934454pubmed:meshHeadingpubmed-meshheading:9934454-...lld:pubmed
pubmed-article:9934454pubmed:meshHeadingpubmed-meshheading:9934454-...lld:pubmed
pubmed-article:9934454pubmed:meshHeadingpubmed-meshheading:9934454-...lld:pubmed
pubmed-article:9934454pubmed:year1998lld:pubmed
pubmed-article:9934454pubmed:articleTitleDual antagonists of platelet activating factor and histamine. 3. Synthesis, biological activity and conformational implications of substituted N-acyl-bis-arylcycloheptapiperazines.lld:pubmed
pubmed-article:9934454pubmed:affiliationDepartment of Chemical Research, Schering-Plough Research Institute, Kenilworth, New Jersey 07033-0539, USA.lld:pubmed
pubmed-article:9934454pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:9934454lld:chembl